Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Chronic Fibrosing ILDs with Progressive Phenotype: Are You Aware of the Latest Data on Diagnosis and Emerging Treatments?

Release Date: July 23, 2020
Expiration Date: July 23, 2021

Activity Overview

This online, on-demand virtual symposium brings together a renowned multidisciplinary group of experts in the management of interstitial lung disease (ILD) who discuss important aspects regarding the early recognition and accurate diagnosis of chronic fibrosing ILD, with the goal of establishing early therapeutic intervention. During this activity, the faculty share their clinical practice insights for making an accurate diagnosis and considering treatment with antifibrotics that can delay disease progression. ILDs with progressive fibrosing phenotypes are reviewed with their unique patterns of fibrosis, along with the role and risks of advanced diagnostic procedures. Clinical management of chronic fibrosing ILDs is covered, culminating in patient case presentations to bring discussions into practice.

This educational activity is an archive of the live virtual symposium held on July 7, 2020.

Acknowledgement of Support

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward pulmonologists, rheumatologists, radiologists, and critical care specialists, as well as nurses, nurse practitioners, physician assistants, and other specialists involved in the management of chronic fibrosing (CF)-ILD.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Assess the pathological patterns of fibrosis in chronic fibrosing ILDs and their role in defining disease etiology and subsequent management;
  • Identify key mechanisms underlying the varied forms of chronic fibrosing ILD, clinical presentation, and management;
  • Improve ability to diagnose chronic fibrosing ILDs earlier in the course of disease to allow for prompt intervention; and
  • Analyze the implications of recent and ongoing clinical research for the treatment chronic fibrosing ILDs.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Steven Nathan, MD
Steven Nathan, MD
Medical Director, Advanced Lung Disease and Lung Transplant Program
Inova Fairfax Hospital
Falls Church, VA

Disclosures: Grant Research Support: Roche/Genentech, Boehringer Ingelheim; Consultant: Roche/Genentech, Boehringer Ingelheim, United Therapeutics, Belleropharm; Speakers Bureau: Roche/Genentech, Boehringer Ingelheim.

Elana J. Bernstein, MD, MSc
Elana J. Bernstein, MD, MSc
Assistant Professor of Medicine
Program Director, Columbia University/NewYork-Presbyterian Scleroderma Program
Division of Rheumatology, Department of Medicine
Columbia University Vagelos College of Physicians and Surgeons
Columbia University Irving Medical Center
New York, NY

Disclosures: Grant Research Support: Boehringer Ingelheim; Consultant: Boehringer Ingelheim.

Christopher S. King, MD, FACP, FCCP
Christopher S. King, MD, FACP, FCCP
Medical Director, Transplant and Advanced Lung Disease Critical Care Program
Inova Fairfax Hospital
Falls Church, VA

Disclosures: Speakers Bureau: Boehringer Ingelheim, Genentech.

Ami N. Rubinowitz, MD
Ami N. Rubinowitz, MD
Associate Professor of Radiology and Biomedical Imaging
Yale School of Medicine and Thoracic Imaging Section
Yale New Haven Hospital
New Haven, CT

Disclosures: Ami N. Rubinowitz, MD has no relevant financial relationships with commercial interest to disclose.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By